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Abstract. It has been suggested that a sub-population of orexinergic neurones whose somata 
lie in the lateral hypothalamic area (LHA) play an important role in regulating the reinforcing 
value of both food and drugs. This experiment examined the effect of disruption of 
orexinergic mechanisms in the LHA on performance on the progressive-ratio schedule of 
reinforcement, in which the response requirement increases progressively for successive 
reinforcers. The data were analysed using a mathematical model which yields a quantitative 
index of reinforcer value and dissociates effects of interventions on motor and motivational 
processes (Killeen, 1994). Rats were trained under a progressive-ratio schedule using food-
pellet reinforcement. They received bilateral injections of conjugated orexin-B-saporin 
(OxSap) into the LHA or sham lesions. Training continued for a further 40 sessions after 
surgery. Equations were fitted to the response rate data from each rat, and the parameters of 
the model were derived for successive blocks of 10 sessions. The OxSap lesion reduced the 
number of orexin-containing neurones in the LHA by approximately 50% compared to the 
sham-lesioned group. The parameter expressing the incentive value of the reinforcer was not 
significantly altered by the lesion. However, the parameter related to the maximum response 
rate was significantly affected, suggesting that that motor capacity was diminished in the 
OxSap-lesioned group. The results indicate that OxSap lesions of the LHA disrupted food-
reinforced responding on the progressive-ratio schedule. It is suggested that this disruption 
was brought about by a change in non-motivational (motor) processes. 
Keywords: orexins – orexin-saporin - operant behaviour – incentive value – motor 
performance – progressive ratio schedule 
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Introduction 
 
Orexin A and B, also known as hypocretin 1 and 2, are neuropeptides that are expressed by 
groups of neurones whose somata lie in the lateral hypothalamic area (LHA) and surrounding 
regions (de Lecea et al., 1998; Date et al., 1999; Peyron et al., 1998; Sakurai et al., 1998). 
Orexinergic neurones project extensively throughout the brain, and the two known types of 
orexin receptor (OX1 and OX2) are expressed in many brain regions (Trivedi et al., 1998). 
 The orexins have been implicated in a variety of neurobehavioural functions, 
including reinforcement, feeding, addiction and regulation of the sleep/wakefulness cycle (de 
Lecea et al., 1998; Sakurai et al., 1998; de Lecea and Sutcliffe, 1999; Sakurai, 1999; Piper et 
al., 2000; Siegel, 2004, 2005; Saper et al., 2005). It has been proposed that the orexinergic 
neurones of the hypothalamus may be divided into two anatomically distinct groups which 
subserve different behavioural functions (‘dichotomy of orexinergic function’: Harris and 
Aston-Jones, 2006). The first group, which consists of the orexinergic neurones of the LHA,  
is purported to be involved in reinforcement mechanisms. The second group, which consists 
of the orexinergic neurones of the dorsomedial hypothalamus (DMH) and perifornical area 
(PFA), is purported to be involved in the regulation of stress and arousal.  
Several lines of evidence support the putative role of the LHA orexinergic projection 
in reinforcement mechanisms. For example, injection of orexin A into the cerebral ventricles 
(Sakurai et al., 1998) or directly into the LHA (Dube et al., 1999; Sweet et al., 1999; Thorpe 
et al., 2005) induces feeding in rodents. Consumption of high-energy diet has been found to 
be preferentially enhanced by orexin A (Clegg et al., 2002), and the orexin receptor 
antagonist 1-(2-methylbenzoxazol-6-yl)-3-[1,5]naphthyridin-4-yl urea (SB-334867), 
administered systemically or into the ventral tegmental area (a prominent projection region of 
the LHA orexinergic neurones), has been found to attenuate spontaneous or opiate-induced 
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consumption of high-fat diet (Zheng et al., 2007; Choi et al., 2010).  More direct evidence for 
an involvement of orexins in reinforcement processes derives from the finding that 
conditioned place preference induced by food or opiate reinforcement is associated with 
activation of LHA orexinergic neurones, and that conditioned place preference can be 
attenuated by systemic administration of SB-334867 (Harris et al., 2005). Stimulation of 
these neurones by injection of rat pancreatic polypeptide into the LHA was found to reinstate 
a previously extinguished conditioned place preference for morphine, and this effect was also 
blocked by SB-334867 (Harris et al., 2005).  
There have been several reports of the effect of manipulating orexinergic function on 
schedule-controlled operant behaviour. Most of these studies have employed the progressive-
ratio schedule of reinforcement, in which the number of responses required in order to obtain 
a reinforcer (the response/reinforcer ratio) is progressively increased (Hodos, 1961; Hodos 
and Kalman, 1963). As the ratio is increased, response rate declines, until the subject 
eventually stops responding, The ratio at which responding ceases for some specified period 
defines the ‘breakpoint’. Administration of orexin A into the third ventricle (Choi et al., 
2010) or directly into the LHA (Thorpe et al., 2005) increased the breakpoint and facilitated 
food intake. Moreover, SB-334867 reduced the breakpoint when the reinforcer was cocaine 
or a highly palatable food (Nair et al., 2008; Borgland et al., 2009; Choi et al., 2010; Sharf et 
al., 2010). Since the breakpoint is often used as an index of the subject’s motivational state or 
the incentive value of reinforcers (Hodos, 1961; Cheeta et al., 1995; Ping-Teng et al., 1996; 
Aberman et al., 1998; Bowman and Brown, 1998; Barr and Phillips, 1999; Thorpe et al., 
2005), these findings are consistent with the notion that the LHA orexinergic projection from 
the LHA forms part of the neural substrate of reinforcement. 
However, it has been argued that some of the findings that have been attributed to the 
putative role of orexinergic mechanisms in reinforcement may also be interpreted in terms of 
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their role in the control of muscle tone and motor output (Siegel, 2004, 2005; Berridge et al., 
2010). Thus, Berridge et al. (2010) have pointed out that increased levels of arousal induced 
by either aversive or appetitive stimuli may facilitate the reinstatement of conditioned place 
preference (Stewart, 2000), and it is therefore possible that the effect of orexinergic 
manipulations on ‘reward seeking’ (Harris et al., 2005) may reflect reward-independent 
changes in arousal rather than changes in the value of positive reinforcers (Berridge et al., 
2010).  
 Moreover, doubts have been raised about the validity of the breakpoint derived from 
progressive-ratio schedule performance as an index of reinforcer value (Arnold and Roberts, 
1997; Mobini et al., 2000; Ho et al., 2003; Killeen et al., 2009; Rickard et al., 2009). 
Although this measure is sensitive to changes in the incentive value of reinforcers (Bizo and 
Killeen, 1997; Rickard et al., 2009), it is also affected by non-motivational variables such as 
the height of the operant lever (Aberman et al., 1998; Skjoldager et al., 1993) or the ratio step 
size (Stafford and Branch, 1998). It has also been noted that there is no clear consensus about 
the definition of the breakpoint (Arnold and Roberts, 1998; Killeen et al., 2009). 
Quantitative models of schedule-controlled behaviour provide a means of 
circumventing some of the problems related to the breakpoint, and may offer a more reliable 
basis for discriminating between the effects of neuropharmacological interventions on 
incentive value and motor functions. One such model is Killeen’s Mathematical Principles of 
Reinforcement (MPR: Killeen, 1994; Killeen and Sitomer, 2001). According to this model, 
schedule-controlled responding is determined by three factors: a general excitatory effect of  
reinforcers on behaviour, a biological constraint on responding imposed by the response 
requirement and the physical capacities of the organism, and the efficiency with which 
particular reinforcement schedules couple operant responses to reinforcers. In the case of 
ratio schedules, in which N responses are required to obtain a reinforcer delivery, response 
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rate, R, is predicted by the following equation: 
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The parameter β (‘currency’) represents the extent to which the strengthening effect of the 
reinforcer is focused on the most recent response; δ (‘response time’) expresses the constraint 
on responding; and a (‘specific activation’) is the time for which a reinforcer is able to 
activate behaviour. The function defined by Equation 1 is shown in Fig. 1. β defines the locus 
of the peak of the function, a reduction of β being reflected in a rightward displacement of the 
peak; δ defines the amplitude of the peak, an increase in δ being reflected in a reduction of 
the maximum response rate; and a defines the slope of the descending limb of the function, a 
lower value of this parameter being reflected in a steeper decline of response rate as a 
function of ratio size. The parameter a is purported to provide an index of reinforcer efficacy 
or ‘value’ (Reilly, 2003). In keeping with this notion, it has been found that there is a 
monotonic relation between reinforcer size and this parameter (Rickard et al., 2009). The 
‘extinction ratio’ is the point of intersection of the curve with the abscissa, in other words, the 
size of the ratio (N) at which the subject stops responding. This theoretical expression of the 
empirical breakpoint is jointly determined by a and δ. This implies that a change in the 
breakpoint may be brought about not only by a change in the incentive value of the reinforcer 
(a) but also by non-motivational factors encapsulated in δ.  
Equation 1 was originally developed to describe performance on fixed- and variable-
ratio schedules; however it also provides a good description of overall response rates on 
progressive-ratio schedules (Ho et al., 2003; Killeen et al., 2009; Rickard et al., 2009). 
Application of Equation 1 to progressive-ratio schedule performance has been used 
successfully to detect the effects of brain lesions and drug administration on motivational and 
motor-related processes (Bezzina et al., 2008a, 2008b; Ho et al., 2003; Kheramin et al., 2005; 
Mobini et al., 2000; Zhang et al., 2005a, 2005b).  
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A recent study of the effect of reinforcer size on progressive-ratio schedule 
performance (Rickard et al., 2009) revealed that while Equation 1 provided a good 
description of overall response rate, its fit to the ‘running’ response rate (response rate 
calculated after exclusion of the post-reinforcement pause: Bizo et al., 2001) was less 
satisfactory. Running response rate was, however, well described by the logistic function: 
  R = Ri /(1+[N/b]
c
)         [2] 
where Ri is a parameter expressing the initial (maximum) response rate, b expresses the rate 
of decay of the function, and the exponent c modulates the curvature of the function. Rickard 
et al. (2009) found that b was was monotonically related to reinforcer size, while Ri was 
unaffected by changes in reinforcer size.  
The aim of the present experiment was to provide further information about the effect 
of disruption of orexinergic mechanisms in the LHA on operant behaviour using a 
quantitative analysis of performance on the progressive-ratio schedule. Changes in the 
parameters of Equations 1 and 2 induced by the lesion were used to infer changes in 
reinforcer value and motor capacity. Disruption of orexinergic mechanisms was brought 
about by injection of an orexin-B-saporin conjugate (OxSap) into the LHA. This neurotoxin 
destroys neurones that express OX2 receptors, including orexinergic neurones, thereby 
disrupting the local neuronal circuitry that depends on orexinergic neurotransmission  
together with the orexinergic output from ths area (Gerashchenko et al., 2001; see below 
[Discussion] for review). The effects of the lesion on locomotor behaviour, food consumption 
and body weight were also examined.  
 
Methods 
 
The experiments were carried out in accordance with UK Home Office regulations governing 
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experiments on living animals.  
 
Subjects 
Thirty experimentally naive female Wistar rats approximately 4 months old and weighing 
250–300 g at the start of the experiment were used. They were housed under a constant cycle 
of 12 h light and 12 h darkness (light on 06:00 - 18:00), and were maintained at 80% of their 
initial free-feeding body weights throughout the operant behaviour experiment by providing a 
limited amount of standard rodent diet after each experimental session. Tap water was freely 
available in the home cages. 
 
Surgery 
The rats were divided into two groups. The first group received bilateral lesions of the LHA 
with the orexin-B-saporin conjugate (OxSap: Advanced Targeted Systems, USA) (n=14). 
The control group was divided into two sub-groups which received either bilateral intra-LHA 
injections of unconjugated saporin (Advanced Targeted Systems, USA) (n=8), or (ii) bilateral 
intra-LHA injections of the vehicle solution alone (0.9% sodium chloride solution) (n=8). 
Anaesthesia was induced with isoflurane (4% in oxygen), and the animals were placed in a 
stereotaxic instrument (David Kopf), with the upper incisor bar set 3.3 mm below the inter-
aural line. Isoflurane was kept at 2% in oxygen during the surgical procedure. A small hole 
was drilled through the skull overlying each cerebral hemisphere for microinjection of the 
solutions into the LHA.  The following coordinates were used to locate the LHA: AP -3.3, L 
± 1.6, V -9.1, measured from bregma (Paxinos and Watson, 1998). 
Microinjections were administered with a 5 μl Hamilton syringe connected by a 
polyethylene tube to a 0.3-mm diameter cannula. The solution administered to the first group 
contained 15 ng OxSap dissolved in 0.3 μl nonpyrogenic 0.9 % sodium chloride (Baxter 
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Health Care, UK). (The dose used was based in preliminary studies carried out in this 
laboratory in which it was found that doses of 180 ng, 90 ng and 45 ng of OxSap produced 
substantial tissue damage of the LHA and surrounding areas. Furthermore these doses 
produced significant reductions of food intake and loss of body weight which necessitated 
euthanasia of most animals 2-3 weeks after surgery.)  The cannula was slowly lowered to the 
target position, and the solution was injected during a 60-s period. The cannula was left in 
position for 3 minutes after completion of the injection, and was then withdrawn. The 
procedure for the other two groups was identical except that the injections were either 15 ng 
unconjugated saporin in 0.3 μl saline (n=8) or 0.3 μl of the saline solution (n=8). 
  
Apparatus 
 Operant behaviour chambers. The rats were trained in custom built operant 
conditioning chambers of internal dimensions 20 cm × 23 cm × 22.5 cm. One wall of the 
chamber contained a recess into which a motor-operated dispenser could deliver 45-mg food 
pellets (TestDiet, MLab Rodent Tablet 45 mg; Sandown Scientific, UK). An aperture was 
situated 5 cm above and 2.5 cm to the left of the recess, through which a motor-operated 
retractable lever could be inserted into the chamber. The lever could be depressed by a force 
of approximately 0.2 N. The chamber was enclosed in a sound-attenuating chest; masking 
noise was provided by a rotary fan. An Acorn 5000 microcomputer and interface unit (Paul 
Fray Ltd.), programmed in ARACHNID BASIC and located in an adjoining room, controlled 
the schedules and recorded the behavioural data.  
 Locomotor behaviour chambers. Locomotor behaviour was recorded in transparent 
Perspex boxes of internal dimensions 42 cm × 32 cm × 29 cm. Each box was equipped with 
eight infrared photocell beams located at equal intervals along the long axis of the box, 4 cm 
above the floor. An Acorn microcomputer programmed in ARACHNID BASIC and located 
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in an adjoining room, recorded the data.  
 
Behavioural procedures 
 Progressive ratio schedule. Two weeks before the start of behavioural training, the 
food deprivation regimen was introduced and the rats were gradually reduced to 80% of their 
free-feeding body weights. Then they were trained to press the lever for a food-pellet 
reinforcer (45 mg) and were exposed to a fixed-ratio 1 schedule for 3 sessions, followed by 
fixed-ratio 5 for a futher 3 sessions. Thereafter, they underwent daily training sessions under 
the progressive-ratio schedule. The progressive-ratio schedule was based on the following 
exponential progression: 1, 2, 4, 6, 9, 12, 15, 20, 25, 32, 40, 50, . . . , derived from the 
formula [(5×e
0.2n)−5], rounded to the nearest integer, where n is the position in the sequence 
of ratios (Roberts and Richardson, 1992). Sessions took place at the same time each day 
during the light phase of the daily cycle (between 07:00 and 14:00) 7 days a week for the 
duration of the experiment. At the start of each session, the lever was inserted into the 
chamber; the session was terminated by withdrawal of the lever 50 min later. The rats were 
trained under the progressive-ratio schedule until the estimated parameters of Equation 1 (see 
Data analysis) had attained stability according to the following criterion. Each parameter was 
deemed to be stable when the cumulated change in the group mean value of the parameter 
over three successive blocks of 10 sessions was ≤ 10%. The value of parameter a increased 
steadily over 60 sessions and the formal criterion was not met until the 10
th
 block. Surgery 
was carried out after 110 training sessions. Training continued for 40 sessions after surgery.    
Locomotor behaviour. Each rat was tested at the same time of day, and under the 
same food restriction conditions as in the operant behaviour experiment. Each session was 30 
min in duration and the data were recorded in 6 successive epochs of 5 min. The tests took 
place 23 h after the last meal. The rats underwent the locomotor activity testing on 7 
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successive days: 5 habituation sessions and two recording sessions.  
 Food intake. Food intake tests took place in the animal holding room. Each rat was 
placed in a cage similar to the home cage containing a pre-weighed dish containing 
approximately 25 g of the same 45-mg food pellets as were used in the operant behaviour 
experiment. The rats were left undisturbed for 60 min before being returned to their home 
cages. The dishes were re-weighed and the weight of food consumed was calculated. Three 
test sessions were carried out at intervals of 48 h while the rats were maintained under the 
same food deprivation conditions as in the operant behaviour experiment. In a second phase, 
the same procedure was carried out while the rats had free access to standard chow in their 
home cages. In this phase, the amount of chow consumed in 23 hours was also measured. 
 
Immunohistochemistry 
At the end of the behavioural experiment, the rats were deeply anaesthetised with sodium 
pentobarbitone, and perfused transcardially with phosphate-buffered sodium chloride solution 
(PBS), followed by 10% formol PBS. The brains were removed from the skull and fixed in 
formol PBS for 3 days. Coronal sections (60-μm) were taken through the LHA region using a 
freezing microtome. Alternate sections were selected for labelling of neurone-specific nuclear 
protein (NeuN) and orexin. 
NeuN was labelled as described by Jongen-Relo and Feldon (2002). The protocol 
followed was described by Bezzina et al. (2007). Three freshly sliced sections, taken at 
approximately 120-µm intervals between AP +3.0 and AP +3.6 were washed in 0.1 M PBS 
and placed in 0.5% H2O2 in PBS for 30 min at room temperature. Then they were washed 
twice in PBS and placed for 1 h in a blocking solution [10% normal horse serum (Vector 
Laboratories, Peterborough, UK), 1% bovine serum albumin (BSA, Sigma-Aldrich, 
Gillingham, UK) and 0.3% Triton X-100 (Sigma-Aldrich) in PBS]. They were then incubated 
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for 48 h at 4°C in the primary antibody [monoclonal mouse anti-NeuN serum (1:5,000, 
Chemicon, Chandlers Ford, UK) in 1% normal horse serum, 1% BSA and 0.3% Triton X-100 
in PBS], washed twice in PBS, and incubated for 2 h at room temperature in biotinylated 
horse antimouse serum (Vector Laboratories; 1:1,000 in 1% BSA and 0.3% Triton X-100 in 
PBS). After two washes in PBS, they were placed for 2 h in avidin–biotin–horseradish 
peroxidase complex (1:200, ABC-Elite, Vector Laboratories) in PBS. Following two further 
washes in PBS, they were placed in a chromagen solution [0.05% diaminobenzidine (Sigma-
Aldrich) and 0.01% H2O2 (Sigma-Aldrich)] for 5 min. The reaction was observed visually 
and stopped by washing in PBS. The sections were floated on to chrome-gelatine-coated 
slides and mounted with DPX.  
 The procedure for orexin staining was the same as that described above, with the 
exception that the primary antibody was goat anti-orexin diluted 1:5,000 in PBS (Santa Cruz 
Biotechnology, USA) and the secondary antibody was horse anti-goat serum 1:1000.  
NeuN-positive nuclei and orexin-positive neurones were counted blind from coded 
images of the sections using Image-J software (Wayne Rasband, National Institutes of 
Health, USA) .  
 
Data analysis  
The data from one rat belonging to the sham lesioned group were discarded, because this rat 
failed to complete a sufficient number of ratios in each session to permit curve fitting analysis 
to be performed. A preliminary analysis comparing the immunohistochemical data and post-
surgical performances of the two control sub-groups (i.e. the rats that received intra-LHA 
injections of unconjugated saporin and the saline vehicle) revealed no significant differences 
between the numbers of orexin-positive neurones or NeuN-positive nuclei or any of the 
performance measures, and therefore the data from the two sub-groups were pooled in all 
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subsequent analyses. Analyses were thus based on the data from the OxSap-lesioned group 
(n=14) and the combined sham-lesioned group (n=15).  
 Operant behaviour data. Data from the last block of 10 sessions before surgery and 
the four successive blocks of 10 sessions following surgery were used in the analyses. 
 Peak response rate. Differences between the highest overall response rate (see below) 
attained during performance of the progressive-ratio schedule during the final pre-surgical 
block of sessions and the four post-surgical blocks were analysed by two-factor analysis of 
variance (group × block) with repeated measures on the latter factor. In the case of a 
significant main effect of group or a significant interaction term, comparisons were made 
between groups at each block using the least significance difference test. 
 Highest completed ratio and breakpoint. The breakpoint was defined as the last ratio 
to be completed before 5 min elapsed without any responding (Hodos 1961; Hodos and 
Kalman 1963). In most cases, this was identical to the highest ratio completed in the session. 
However, in some cases, this criterion was not met within the 50-min session. Therefore, the 
highest completed ratio and the breakpoint were analysed separately. The data were analysed 
in the same way as the peak response rate. Analysis of the highest completed ratio 
incorporated the data from all sessions, whereas analysis of the breakpoint entailed exclusion 
of data from sessions in which the formal breakpoint criterion was not attained. 
 Overall response rate. Overall response rate was calculated for each ratio using the 
total time taken to complete the ratio, including the post-reinforcement pause, measured from 
the end of the preceding reinforcer delivery until the emission of the last response of the ratio 
(Bizo and Killeen, 1997). The first ratio (a single response) and any ratios that had not been 
completed at the end of the session were excluded from the analysis. The raw data from the 
final pre-surgical and the four post-surgical blocks of 10 sessions were analysed by three-
factor analysis of variance (group × block × ratio) with repeated measures on the second and 
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third factors. Equation 1 was fitted to the overall response rate data from each rat using an 
iterative least-squares method (SigmaPlot, Version 8.0), and the estimated values of the 
parameters β, δ and a were derived; goodness of fit was expressed as r2, the proportion of the 
data variance accounted for by the equation. In agreement with previous findings (Mobini et 
al., 2000; Ho et al., 2003; Zhang et al., 2005a, 2005b; Bezzina et al., 2008a, 2008b; Rickard 
et al., 2009), examination of the data revealed that in some rats very low response rates were 
generated under the highest ratios, which did not conform to Equation 1. Therefore the 
equation was fitted to each rat’s data after exclusion of these low rates using the following 
operational criterion (Mobini et al., 2000). Points were removed successively, starting from 
the highest ratio completed, when the curve-fitting routine generated an abscissa intersection 
point (a/δ) which lay to the left of the rightmost empirical datum point; such an intersection 
implies a negative predicted response rate, which is impossible empirically, and specifically 
precluded by the model (see above, Equation 1). A fit was accepted when the predicted 
response rates for all the surviving data points had positive values. This procedure seldom 
eliminated more than one datum point from the data sets derived from individual rats. A 
preliminary analysis of the estimates of the three parameters of Equation 1 (a, δ and β) in 
successive blocks of 10 sessions before surgery (analysis of variance: group × block) was 
carried out in order to check that there were no significant between-group differences in the 
pre-surgical data. Then the post-surgical changes of the estimates of the three parameters 
obtained during the final pre-surgical block of sessions and the four post-surgical blocks were 
analysed in the same way as the highest completed ratio and peak response rate. An 
additional analysis comparing the fits of Equation 1 to data from the pre-surgical and final 
post-surgical blocks in each group was carried out with non-linear mixed effect modelling 
using the maximum likelihood approach (Pinheiro and Bates 2004).  
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Running response rate. Running rate was calculated by dividing the number of 
responses by the ‘run-time’ (i.e. the time taken to complete the ratio, excluding the post- 
reinforcement pause: Bizo et al., 2001). The data were analysed as described above. Equation 
2 was fitted to the running rate data from the individual rats and post-surgical changes in the 
parameters were analysed in the same way as the parameters of Equation 1.  
 Because the number of ratios completed within a session under a progressive-ratio 
schedule differs among individual subjects, analyses of variance of the raw response rates 
included only those ratios that were completed by at least 75% of the rats in each group in 
each phase of the experiment (ratios up to and including 62), missing values being filled 
using the value obtained in the highest ratio completed by the subject in question (Rickard et 
al., 2009). (Note that this limitation did not apply to the quantitative analysis of response 
rates using Equations 1 and 2, which entailed fitting functions to the data from individual 
rats.) 
 Locomotor activity data. Data were averaged across the two test sessions. The total 
numbers of beam breaks recorded in successive 5-min epochs were analysed by two-factor 
analysis of variance (group × epoch) with repeated measures on the latter factor. 
 Food intake data. Comparisons between groups were made using Student’s t-test.  
 A significance criterion of p≤0.05 was adopted in all statistical analyses. 
 
Results 
 
Operant behaviour data 
 Peak response rate. The mean (±SEM) post-/pre-surgical differences in peak 
response rate for the sham-lesioned and the OxSap-lesioned group are shown in Fig. 2 (left-
hand panel). Analysis of variance revealed no significant main effects of group [F(1,27) = 
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2.24,  NS] or block [F<1]. However there was a significant group × block interaction [F(3,81) 
= 4.26, p<0.01], reflecting a decrement of the maximum response rate in the OxSap-lesioned 
group in the last three blocks of sessions after surgery. 
 Highest completed ratio and breakpoint. Both the highest completed ratio (Fig. 2, 
middle panel) and the breakpoint (Fig. 2, right-hand panel) were somewhat reduced after 
surgery, the reduction appearing slightly greater in the OxSap-lesioned group than in the 
sham-lesioned group. However, analysis of variance of the highest completed ratio revealed 
no significant main effect of group [F<1] or block [F(3,81) = 1.05, NS] and no significant 
interaction [F<1]. In the case of the breakpoint, there was a significant effect of block 
[F(3,69) = 3.0, p<0.05], but no significant effect of group and no significant interaction 
[Fs<1]. 
 Overall response rate. Fig. 3 shows the estimates of the parameters of Equation 1 in 
successive blocks of 10 sessions in the pre-surgical phase of the experiment. The parameter a 
showed a progressive increase during training, and the formal stability criterion (see above: 
Method) was not attained until the 10
th
 block of sessions. Analysis of variance revealed a 
significant main effect of block [F(10,270) = 10.9, p<0.001], but no significant effect of 
group and no significant interaction [Fs<1]; moreover there was no significant difference 
between the groups in the final pre-surgical block [t(27) = 0.6, NS]. The other two parameters 
(δ and β) remained relatively stable during the training phase, there being no significant 
differences between the two groups across the eleven blocks [all Fs<1.2, NS] nor any 
significant difference in the final-pre-surgical block. [δ: t(27) = 0.8, NS; β: t(27) = 0.5, NS] 
Fig. 4 shows the group mean overall response rate data for the sham-lesioned (left hand 
panel) and OxSap-lesioned groups (right hand panel) in the last pre- and post-surgical blocks 
of sessions. In both groups, response rate increased rapidly to a peak, and then gradually 
declined as the response/reinforcer ratio was progressively increased. The maximum response 
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rate was reduced in the Ox-Sap lesioned group following surgery.  The fits of Equation 1 to 
the group mean data accounted for >90% of the total variance (sham lesion: pre-surgery, r
2
 = 
0.93; post-surgery, r
2
 = 0.90; OxSap lesion: pre-surgery, r
2
 = 0.94; post-surgery, r
2
 = 0.92). 
There were significant main effects of block [F (4,108) = 6.2,  p<0.001] and ratio [F(11,297) 
= 20.1, p<0.001], but not of group [F<1]. There were significant group × block [F(4,108) = 
4.5, p<0.01] and block × ratio [F(44,1188) = 1.9, p<0.01] interactions; the group × ratio and 
three-way interactions were not significant [Fs<1]. 
 Fig. 5 shows the changes in the parameters of Equation 1 following surgery.   
‘Specific activation’, a. There was no significant main effect of group [F<1] or block 
[F(3,81) = 1.1, NS], and no significant group × block interaction [F<1]. 
 ‘Response time’, δ. There was a significant main effect of group [F(1,27) = 5.6, 
p<0.05], but not of block [F(3,81) = 2.1, NS]. There was a significant group × block 
interaction [F(3,81) = 2.3, p<0.05]. Multiple comparisons indicated that there was a 
significant increase in δ in the OxSap-lesioned group, compared to the sham-lesioned group 
in the second, third and fourth post-surgical blocks. 
 ‘Currency’, β. There was no significant main effect of group [F<1] or block [F(3,81) 
= 1.5, NS], and no significant interaction [F (3,81) = 1.3, NS]. 
The fits of Equation 1 to data from the final pre-surgical and post-surgical blocks 
were also analysed by non-linear mixed effect modelling using the maximum likelihood 
approach (see Pinheiro and Bates 2004). First, a fixed effect of block was not included in the 
model (model i). Then the model was modified to incorporate block as a fixed effect (model 
ii). In the case of the sham-lesioned group, it was found that block did not account 
significantly for the variability in either a [t(443) = 1.85, NS] or δ [t(443) = 1.3, NS], and 
comparison of models i and ii indicated no advantage of including block as a fixed effect 
[Akaike Information Criterion (AIC): model i, 4091.5; model ii, 4091.8; Likelihood Ratio 
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(LR) = 3.7, NS]. In the case of the OxSap-lesioned group, there was no significant effect of 
block on the estimate of a [t(424) = 1.3, NS]; however block exerted a significany influence 
on the estimate of δ [t(424) = 12.9, p<0.001]. A version of the model that incorporated an 
effect of block on δ but not on a (model iii) provided a better account of the data than the 
simpler model i [AIC: model i, 4033.8; model iii, 3801.3; LR = 234.5, p<0.001]; addition of 
the fixed effect of block on a (model ii) conferred no further advantage [AIC: model ii, 
3802.5; model ii versus model iii: LR = 0.8, NS]. 
 Running response rate. Fig. 6 shows the group mean running response rate data for 
the sham-lesioned (left-hand panel) and OxSap-lesioned groups (right-hand panel) in the last 
pre- and post-surgical blocks of sessions. In both groups, running rate declined monotonically 
as a function of the ratio requirement. Running rates were reduced following surgery in the 
OxSap-lesioned group. The fits of Equation 2 to the group mean data accounted for about 
95% of the total variance. There were significant main effects of block [F (4,108) = 7.2,  
p<0.001] and ratio [F(11,297) = 115.2, p<0.001], but not of group [F<1]. There was a 
significant group × block [F(4,108) = 10.0, p<0.01] interaction; the block × ratio [F(44,1188) 
= 1.2, NS], group × ratio [F<1] and three-way interactions [F<1] were not significant. 
 Fig. 7 shows the changes in the parameters of Equation 2 following surgery.   
‘Initial running rate’, Ri. There was a significant main effect of group [F(1,27) = 4.9, 
p<0.05], reflecting a lower value of this parameter in the OxSap-lesioned group than in the 
sham-lesioned group. The main effect of block [F<1] and the interaction [F(3,81) = 1.7, NS], 
were not significant. 
 ‘Decay parameter’, b. There was no significant main effect of group [F<1] or block 
[F<1], and no significant interaction [F(3,81) =1.2, NS]. 
 ‘Exponent’, c. There was no significant main effect of group [F(1,27) = 2.7, NS] or 
block [F<1], and no significant interaction [F<1]. 
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Locomotor activity data 
Fig. 8 shows the locomotor activity data in successive 5-minute epochs of the 30-min 
test sessions. There was a significant main effect of epoch [F(5,135) = 18.9, p<0.001], 
reflecting  the decline in activity after the first epoch. There was no significant main effect of 
group or group × epoch interaction [Fs<1]. 
 
Food intake and body weight 
Feeding tests. Table 1 shows the total weights of 45-mg food pellets consumed 
during the 60-min tests under the food-restricted and free-feeding conditions. In neither case 
did food consumption differ between the two groups [t<1 in each case]. Consumption of 
standard chow during the 23 hours between feeding tests under the free-feeding condition did 
not differ between the groups [t(27) = 1.0, NS].  
Body weight. During the operant behaviour experiment, the rats’ body weights were 
maintained at 80% of their initial free-feeding weights. There was no significant difference 
between the weights of the food rations needed to maintain the criterion weights in the two 
groups [group × blocks of sessions: all Fs<1]. On return to the free-feeding condition, the 
body weights of both groups rapidly increased to their free-feeding levels; there was no 
significant difference between the two groups  [t(27) = 1.5, NS; see Table 1]. 
 
Immunohistochemistry 
 Fig. 9 shows representative photomicrographs of sections stained for orexin (upper 
panels) and NeuN (lower panels). OxSap resulted in a marked loss of orexin-positive 
neurones from the LHA with a smaller loss from the perifornical region. Numerical data are 
shown in Fig. 10. There was a significant reduction of the number of orexin-positive 
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neurones in the LHA [approximately 50% reduction: t(27) = 3.7, p<0.001], whereas the 
reduction fell short of statistical significance in the case of the perifornical area [t(27) = 1.5, 
NS]. There was a small reduction of the number of NeuN-positive nuclei in the LHA in the 
lesioned group [approximately 12% reduction: t(27) = 1.9, p = 0.06]; there was no significant 
difference between the two groups in the case of the perifornical area [t<1]. 
 
Discussion 
 
Injection of the OxSap neurotoxin into the LHA produced a significant depletion of orexin-
containing neurones from the LHA. The lesion was most pronounced in the LHA. Some loss 
of orexinergic neurones was evident in the perifornical region in some rats; however, this was 
not statistically significant in the group as a whole. The destruction of orexinergic neurones 
by local injection of OxSap into the LHA is consistent with previous reports (Gerashchenko 
et al., 2001, 2003; Blanco-Centurion et al., 2007; Furlong and Carrive, 2007; Frederick-Duus 
et al., 2007; Vetrivelan et al., 2009; Anaclet et al., 2010; Di Sebasiano et al., 2010, 2011). 
OxSap, a conjugate of orexin-B with the ribosome-inactivating protein saporin, acts by 
binding to OX2 orexin receptors, thereby destroying neurones that express these receptors. 
Since orexinergic neurones possess OX2 receptors, these neurones fall victim to the 
neurotoxin. However, some other neuronal populations within in the LHA also possess OX2 
receptors (see below), and it is likely, therefore, that these other neurones were also affected 
by the lesion.  
It is well established that orexinergic neurones of the LHA are susceptible to the 
neurotoxic effects of OxSap; however the relative vulnerability of other neuronal phenotypes 
remains controversial. In an early study employing OxSap, Gerashchenko et al. (2001) found 
that in addition to orexin-containing neurones, melanocortin concentrating hormone (MCH)-
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containing neurones were also destroyed by OxSap, whereas neurones expressing a-
melanocyte-stimulating hormone were resiliant. The susceptibility of MCH-containing 
neurones to destruction by OxSap has been confirmed in some subsequent studies (Furlong 
and Carrive, 2007; Ocampo-Garces et al., 2011). However, there is evidence that MCH-
containing neurones may be less vulnerable than orexin-containing neurones (Frederick-Duus 
et al., 2007), and indeed some authors found that injections of OxSap into the LHA which 
produced profound loss of orexinergic neurones had no significant effect on the numbers of 
MCH-containing neurones in this area (Di Sebastiano et al., 2010, 2011). It is generally 
agreed that hypothalamic histaminergic neurones are sensitive to OxSap (Blanco-Centurion et 
al., 2007; Luo and Leung, 2010), as are cholinergic neurones on the lateral dorsal tegmentum 
(Blanco-Centurion et al., 2004). Interestingly, noradrenergic neurones of the locus coeruleus 
have been found to be resistant to OxSap, probably reflecting the fact that these orexin-
sensitive neurones express OX1 rather than OX2 receptors (Blanco-Centurion et al., 2004).  
The relative selectivity of OxSap for OX2 receptor-bearing neurones appears to be 
dose-dependent. High doses of OxSap generally produce non-selective neuronal loss 
(Mistlberger et al., 2003; Gerashchenko et al., 2006; Furlong and Carrive, 2007), whereas the 
effect of lower doses tends to be more selective (Gerashchenko et al., 2006; Vetrivelan et al., 
2009; Anaclet et al., 2010). In the present experiment, the number of neurones destroyed by 
OxSap appears to have been a relatively small proportion of the total population of neurones 
in the affected region, as indicated by the modest reduction of the number of NeuN-positive 
nuclei seen in the OxSap-lesioned group compared to the sham-lesioned group (relative loss, 
12%; p=0.06). This is consistent with the results of some previous studies which employed 
low doses of OxSap (Gerashchenko et al., 2006; Di Sebastiano et al., 2010, 2011). Therefore, 
taking all these factors into account, we suggest that while the lesion used in this experiment 
produced a substantial depletion of orexinergic neurones from the LHA and presumably 
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induced a major disruption of orexinergic output from this area, it is not possible to quantify 
the contribution of a putative loss of other orexin (OX2) receptor-bearing neurones of the 
LHA to the behavioural effects of the lesion. 
 The performance of both the sham-lesioned and OxSap-lesioned groups on the 
progressive-ratio schedule was similar to that seen in many previous studies (Bizo and 
Killeen, 1997; Mobini et al., 2000a; Ho et al., 2003; Kheramin et al., 2005; Zhang et al., 
2005a, 2005b; Bezzina et al., 2008a, 2008b; Killeen et al., 2009; Rickard et al., 2009). 
Overall response rate was bitonically related to ratio size; it increased rapidly to reach a peak, 
and then declined gradually as the response/reinforcer ratio was progressively increased. The 
running response rate declined monotonically as a function of the ratio size. In agreement 
with these previous studies, overall response rates on the progressive-ratio schedule were 
well described by Equation 1 and running rates by Equation 2. 
 It has been proposed that orexinergic neurones of the LHA play an important role in 
reinforcement processes and that, consequently, inactivation of these neurones reduces the 
rewarding value of food and other reinforcers (Harris et al., 2005; Harris and Aston-Jones, 
2006; Aston-Jones et al., 2009; Cason et al., 2010; Sharf et al., 2010). As discussed above, 
the progressive-ratio schedule has been widely used as a method for evaluating the efficacy 
of reinforcers (see Introduction for references). It was therefore expected that destruction of 
orexinergic neurones of the LHA would suppress responding on this schedule. However, 
Killeen’s (1994) theoretical analysis of reinforcement schedules indicates that suppression of 
responding on ratio schedules may be caused not only by a reduction of reinforcer efficacy 
(represented by the parameter a) but also by an increase of the time required to emit an 
operant response (represented by the parameter δ). A change in either or both of these 
parameters is expected to alter the traditional index of progressive-ratio schedule 
performance, the breakpoint.  
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In contrast to the parameters of Equation 1, which are derived from analysis of the 
response rates generated by the entire sequence of ratios in the schedule, the breakpoint is 
defined by a single point, the ratio at which responding ceases for some predefined period 
(see Introduction). As time-constrained sessions were employed in this experiment, the 
breakpoint criterion was not achieved by all rats in all sessions, and analysis of the breakpoint 
data excluded those sessions in which the breakpoint criterion was not met. As an additional 
measure, which did not entail exclusion of data, the highest ratio completed in the session 
was also analysed (Zhang et al., 2005a, 2005b; Rickard et al., 2009). Although both measures 
showed a tendency to to be reduced following the OxSap lesion, the change was not 
statistically significant in either case. 
Application of Equation 1 to the overall response rate data indicated that the OxSap 
lesion had no significant effect on a, suggesting that the lesion did not alter the intrinsic value 
of the reinforcer. This conclusion is supported by the analysis of the running rate data using 
Equation 2, which showed that the decay parameter, b, which has recently been shown to be 
systematically related to reinforcer value (Rickard et al., 2009), was not significantly altered.  
 On the other hand, the OxSap lesion produced a substantial increase in the ‘response 
time’ parameter, δ, of Equation 1, a reduction of the ‘initial response rate’ parameter, Ri, of 
Equation 2, and a reduction of the peak response rate. Since δ specifies the minimum time 
required to execute an operant response, the increase of this parameter in the OxSap-lesioned 
group is consistent with an impairment of motor capacity. The reduction of Ri is also 
consistent with this interpretation, and it is noteworthy that, unlike δ, Ri is not influenced by 
the duration of the post-reinforcement pause; therefore the reduction of this parameter cannot 
readily be attributed to subtle changes in post-prandial behaviour in the lesioned group (see 
Bezzina et al., 2008a, 2008b; Rickard et al., 2009). Ri has been found to be impervious to 
changes in reinforcer magnitude (Rickard et al., 2009), which further argues against the 
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possibility that the effect of the lesion might have been caused by a change in reinforcer 
value. 
  An impairment of motor function induced by the OxSap lesion is consistent with 
previous reports that stimulation of orexinergic mechanisms increases, and suppression of 
orexinergic mechanisms reduces, postural muscle tone and motor output (Ida et al., 1999; 
Hara et al., 2001; Jones et al., 2001; Kiyashchenko et al., 2001; Wu et al., 2002; Torterolo et 
al., 2003; Takakusaki, 2008; Anaclet et al., 2009). 
The lack of effect of the lesion on the parameters of Equations 1 and 2 that are related 
to the incentive value of reinforcers is in apparent disagreement with previous findings that 
are consistent with the notion that the LHA orexinergic projection is critically involved in 
determining reinforcer efficacy. Evidence consistent with this proposition derives from a 
range of pharmacological manipulations (e.g., systemic or central administration of orexin 
receptor antagonists: Clegg et al., 2002; Harris et al., 2005, 2006; Zheng et al., 2007; 
Borgland et al., 2009; central administration of orexin or its precursor: Thorpe and Kotz, 
2005; Thorpe et al., 2005; Choi et al.., 2010), and a variety of behavioural paradigms (e.g., 
conditioned place preference: Harris et al., 2005, 2007; Narita et al., 2006; consumption of 
palatable diet: Clegg et al., 2002; Zheng et al., 2007; Nair et al., 2008; Borgland et al., 2009; 
Sharf et al., 2010; performance on progressive-ratio schedules: Thorpe et al., 2005; Borgland 
et al., 2009; Choi et al., 2010). Several methodological factors may have contributed to the 
apparent discrepancy between the present findings and the results of previous experiments. 
Firstly, it may be noted that no previous investigation of the effect of manipulating 
orexinergic function on reinforcement processes has used the neurotoxin OxSap to destroy 
LHA orexinergic neurones. In the present experiment, OxSap injected into the LHA induced 
a 50% loss of orexin-containing neurones from this area. It is possible that a more extensive 
depletion may be required in order to reveal an effect on the incentive value of food 
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reinforcers.  
Another potentially important factor is the level of food deprivation. The subjects of 
this experiment were maintained at 80% of their free-feeding body weights, whereas most 
previous studies of the effect of manipulating orexinergic function on motivated behaviour 
have been carried out on non-deprived animals or under milder deprivation conditions than 
that used in this experiment (Thorpe et al., 2005; Harris and Aston-Jones, 2006; Borgland et 
al., 2009; Cason et al., 2010; Sharf et al., 2010). It is not clear how this might have 
influenced the results, although the control of food intake is known to be different in non-
deprived and deprived states (Rowland et al., 2001). It is known that in food-deprived 
subjects various pathways in addition to those involving orexinergic mechanisms modulate 
food intake. For example, food deprivation increases immediate-early gene expression in 
neuropeptide-Y containing neurones of the arcuate nucleus (Cummings et al., 2001), and 
plasma ghrelin is elevated by food deprivation (Gerard et al., 1990; Meister, 2007). 
Conceivably, the operation of non-orexinergic mechanisms might have compensated for an 
effect of orexin depletion on reinforcer value in the food-deprived animals used in the present 
study. In this context, it is of interest that Sharf et al. (2010) recently found that the 
performance of mice lacking the orexin precursor prepro-orexin (orexin -/-) on a progressive-
ratio schedule did not differ from that of normal mice. Sharf et al. (2010) suggested that non-
orexinergic mechanisms may have compensated for the lack of orexin in the genetically 
modified animals. 
 Yet another potentially relevant methodological factor is the length of training which 
the rats underwent before surgery. In most previous experiments in which the progressive-
ratio schedule has been used to evaluate the effects of manipulating orexinergic function, the 
initial training period has been in the order of 5-15 sessions (Thorpe et al., 2005; Borgland et 
al., 2009; Choi et al., 2010). Although responding on the progressive-ratio schedule is 
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generally well established within a few days of training, we have found that many sessions 
are required in order to attain stability of the parameters of Equation 1 (Kheramin et al., 
2005; Zhang et al., 2005a, 2005b; Bezzina et al., 2008a, 2008b; Rickard et al., 2009). In the 
present experiment, attainment of the formal stability criterion based on the parameters of 
Equation 1 required approximately 100 training sessions; this was especially apparent in the 
case of the ‘specific activation’ parameter, a (see Figure 3). It is not clear how such 
protracted training might have affected the results of this experiment. There is evidence that 
after extended training learned behaviour tends to become ‘habitual’ and relatively 
insensitive to reinforcer devaluation or changes in motivational level (Dickinson, 1985; Miles 
et al., 2003; de Wit et al., 2010). It is possible that our rats’ extensive experience with the 
progressive-ratio schedule reduced the impact of an OxSap-induced decrease in reinforcer 
value on schedule performance. Further experiments may be warranted to examine the impact 
of prior training on the sensitivity of operant behaviour to manipulation of orexinergic 
function.  
 The ‘currency’ parameter, β, of Equation 1 did not differ significantly between the 
two groups. β expresses the ‘coupling’ of responding to reinforcers, which is purported to be 
determined, in part, by the working memory limitations of the organism (Killeen, 1994). An 
effect of the OxSap lesion on this parameter might therefore have been expected, in view of 
evidence indicating that manipulation of orexinergic function in the medial septum,  
hippocampus and dentate gyrus, whose orexinergic afferents emanate from the LHA, can 
alter mnemonic functions, including working memory (Smith and Pang, 2005; Akbari et al., 
2006, 2008). However, it has yet to be demonstrated experimentally that the empirical value 
of β derived from ratio schedule performance is sensitive to disruption of working memory.  
 There was no significant difference between the spontaneous locomotor activity of the 
OxSap-lesioned and sham-lesioned rats in this experiment. Previous studies have shown that 
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acute central administration of orexins increases spontaneous locomotor behaviour, whereas 
orexin receptor antagonists reduce it (Jones et al., 2001; Thorpe and Kotz, 2005). However, 
orexin deficient rodents have been found to show normal levels of locomotor activity (Sharf 
et al., 2010) or altered activity levels that are restricted to a brief period at the start of the dark 
phase of the daily cycle (Hara et al., 2001). It is possible that alteration of locomotor 
behaviour is not sustained on a chronic basis in the absence of orexinergic function. In this 
experiment the rats underwent locomotor testing approximately six weeks after the OxSap 
lesion had been inflicted. It would be of interest to examine whether locomotor behaviour is 
suppressed at an earlier stage following this lesion. 
Food intake was not affected by the OxSap lesion in this experiment. Previous reports 
have emphasised the preferential effect of orexinergic manipulations on the ingestion of 
especially palatable foods in non-deprived animals (Sakurai et al., 1998; Farr et al., 2005; 
Thorpe et al., 2005; Thorpe et al., 2006; Thorpe and Kotz, 2005; Nair et al., 2008; Borgland 
et al., 2009). The food pellets used in the food intake tests in the present experiment were the 
same as those used in the operant behaviour tests. Although these pellets are more palatable 
than standard laboratory chow, it is possible that they were not sufficiently appetizing to 
reveal an effect of the lesion on food intake.  
In conclusion, the results obtained in this experiment confirm that disruption of 
orexinergic mechanisms in the LHA results in a significant disruption of food-reinforced 
operant behaviour maintained under the progressive-ratio schedule. Quantitative analysis of 
performance based on Killeen’s (1994) mathematical model of schedule-controlled behaviour 
(MPR) indicated that this disruption was not brought about by a change in the incentive value 
of the food reinforcer, but by a change in non-motivational processes that are encapsulated in 
the ‘response-time’ parameter, δ, of Killeen’s (1994) model. This is consistent with the 
suggestion that motor effects may play a more important role in the effects of manipulating 
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orexinergic function on reinforced behaviour than has previously been recognised (Siegel, 
2004, 2005; Berridge et al., 2010). 
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Table 1. Results of food consumption tests and body weight 
 Sham-lesioned 
group 
 OxSap-lesioned 
group 
Consumption of food pellets (g per 60-min session) 
 Food-restricted condition 12.8 ± 0.4  13.2 ± 0.5 
 Free-feeding condition 5.6 ± 0.5  6.1 ± 0.4 
Home-cage chow consumption (g per 23 h) 
 Free-feeding condition 22.4 ± 0.6  23.7 ± 1.1 
Body weight (g) 
 Free-feeding condition 277.8 ± 2.6  283.0 ± 2.7 
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Figure 1.  Theoretical function defined by Equation 1 (Killeen 1994). Ordinate: response 
rate; abscissa: response/reinforcer ratio (N). The (projected) point of intersection of the 
function with the ordinate is at R = 1/δ, and the slope of the descending limb of the function 
is -1/a; the point of intersection with the abscissa (‘extinction ratio’) is jointly determined by 
δ and a (N = a/δ). See text for details. 
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Figure 2. Left-hand panel. Changes in peak response rate following surgery in the sham-
lesioned (open circles) and OxSap-lesioned (filled circles) groups. Ordinate: change in the 
peak response rate (responses min
-1
); abscissa: blocks of 10 sessions. Points are differences 
between the values obtained in the four post-surgical blocks and the final pre-surgical block 
(Pre) (mean ± SEM). Significant difference between groups: * p<0.05. Middle panel: 
Changes in highest completed ratio; right-hand panel: Changes in break point; conventions 
as in left-hand panel. 
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Figure 3. Values of the three parameters of Equation 1 (uper graph: a; middle graph: δ; lower 
graph: β) in successive blocks of 10 sessions during the pre-surgical training phase of the 
experiment. The filled symbols show the mean values for all rats; the open symbols show the 
mean values for the rats that were subsequently allocated to the sham-lesioned group 
(triangles) and the Ox-Sap lesioned group (circles). 
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Figure 4. Overall response rates in successive ratios of the progressive-ratio schedule. Left 
hand panel: data from the sham-lesioned group; right hand panel: data from the OxSap-
lesioned group. Ordinates: response rate (responses min
-1
); abscisae: ratio, N. Points are 
group mean data. Circles: data from the last ten sessions before surgery; triangles: data from 
sessions 31-40 after surgery. The curves are fits of Equation 1 to the data (see text for 
details). Note the reduction of response rates in the OxSap-lesioned group, but not the sham-
lesioned group, following surgery. 
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Figure 5. Changes in the parameters of Equation 1 following surgery in the sham-lesioned 
(open circles) and OxSap-lesioned (filled circles) groups. Ordinates: change in parameter 
value; abscissa: blocks of 10 sessions. Points are differences between the values obtained in 
the four post-surgical blocks and the final pre-surgical block (Pre) (mean ± SEM). Significant 
difference between groups: * p<0.05. Left-hand graph: ‘activation’ parameter, a (s); middle 
graph: ‘response time’ parameter, δ (s); right-hand graph: ‘currency’ parameter, β.  
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Figure 6. Running response rates in successive ratios of the progressive ratio schedule. Left 
hand panel: data from the sham-lesioned group; right hand panel: data from the OxSap-
lesioned group. Ordinates: response rate (responses min
-1
); abscisae: ratio, N. Points are 
group mean data . Circles: data from the last ten sessions before surgery; triangles: data from 
sessions 31-40 after surgery. Note the reduction of response rates in the OxSap-lesioned 
group, but not the sham-lesioned group, following surgery. 
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Figure 7. Changes in the parameters of Equation 2 following surgery in the sham-lesioned 
(open circles) and OxSap-lesioned (filled circles) groups. Ordinates: change in parameter 
value; abscissa: blocks of 10 sessions. Points are differences between the values obtained in 
the four post-surgical blocks and the final pre-surgical block (Pre) (mean ± SEM). Significant 
difference between groups: * p<0.05. Left-hand graph: ‘initial response rate’ parameter, Ri 
(responses min
-1
); middle graph: ‘decay’ parameter, b (s); right-hand graph: ‘exponent’, c. 
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Figure 8. Locomotor activity in the sham-lesioned (open circles) and OxSap-lesioned (filled 
circles) groups in 30-minute sessions. Ordinate: total beam breaks per 5-min epoch; abscissa: 
epochs. Points are group mean data (± SEM).  
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Figure 9. Left-hand panel. Diagram of coronal section of the rat brain at AP -3.3 mm, 
measured from bregma (from Paxinos and Watson 1998). The filled rectangles indicate the 
areas used for counting orexin-positive neurones and NeuN-positive nuclei. LHA, lateral 
hypothalamic area; PFA, perifornical hypothalamic area; MTT, mammillothalamic tract. 
Representative coronal sections through the hypothalamus of a sham-lesioned and an OxSap-
lesioned rat are shown in the middle and right-hand panels; upper panels: sections stained for 
orexin; lower panels: sections stained for NeuN. 
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Figure 10. Left-hand panel. Density of orexin-positive neurones counted in the lateral 
hypothalamic area (LHA) and perifornical hypothalamic area (PFA). Ordinate: counts mm
−2
. 
Columns show the group mean data (+SEM) for the sham-lesioned  (white columns) and the 
OxSap-lesioned (black columns) rats. Difference between groups: * p<0.05. Right-hand 
panel. Density of NeuN-positive nuclei in the LHA and PFA of the two groups (conventions 
as in the left-hand panel). 
 
